Tie pharma CEO pay to fair global COVID-19 vaccine access, investors say
Published by ReutersBy Toby Sterling AMSTERDAM (Reuters) -A group of institutional investors representing $3.5 trillion in assets under management on Thursday called on pharmaceutical companies to link their executives' pay to making COVID-19 vaccines available around the globe. While the majority of citizens of wealthy nations are vaccinated and many…